Ningbo David Medical Device Faces Valuation Shift Amid Mixed Technical Indicators

Ningbo David Medical Device Co., Ltd., a small-cap player in the Pharmaceuticals & Biotechnology sector, has recently undergone an adjustment in its evaluation. This revision reflects a shift in its valuation metrics, moving from a classification of very expensive to expensive. The company's P/E ratio stands at 64, while its Price to Book Value is recorded at 3.29. Additionally, the EV to EBIT and EV to EBITDA ratios are noted at 61.20 and 41.47, respectively. Despite the adjustments in valuation, the technical indicators present a mixed picture. The technical trend has transitioned from sideways to mildly bullish, although several indicators, including MACD and Bollinger Bands, indicate bearish signals on both weekly and monthly bases. The company has faced challenges in long-term growth, with net sales increasing at an annual rate of 3.40% and operating profit declining by 8.50% over the past five years. Moreover, Ningbo David Medical Device has reported negative results for the last four consecutive quarters, with a return on equity of 5.16% and a high dividend yield of 0.64%. The stock has generated a return of 5.69% over the past year, which is significantly lower than the market's performance. Discover the Latest Mojo Score and Financial Trend Performance - SignUp in less than 2 Minutes and get FREE Premium Access.